Saltar al contenido
Merck
Todas las fotos(1)

Key Documents

AB15620

Sigma-Aldrich

Anti-Olig1 Antibody

Chemicon®, from rabbit

Iniciar sesiónpara Ver la Fijación de precios por contrato y de la organización
Todas las fotos(1)

About This Item

UNSPSC Code:
12352203
eCl@ss:
32160702
NACRES:
NA.41

biological source

rabbit

Quality Level

100

antibody form

purified antibody

antibody product type

primary antibodies

clone

polyclonal

species reactivity

rat, mouse

manufacturer/tradename

Chemicon®

technique(s)

immunocytochemistry: suitable
immunohistochemistry: suitable
immunoprecipitation (IP): suitable
western blot: suitable

NCBI accession no.

NM_138983.1

UniProt accession no.

Q8TAK6

shipped in

wet ice

target post-translational modification

unmodified

Gene Information

rat ... Olig1(60394)

Specificity

Olig-1. Recognizes the ~27 kDa Olig-1 protein by Western blot.

Immunogen

Recombinant Olig-1.

Application

Detect the Olig1 protein using this Anti-Olig1 validated for use in IP, WB, ICC & IHC.
Research Category
Neuroscience
Research Sub Category
Neuronal & Glial Markers
Western blot: 1:2,500-1:5,000 on rat and mouse.
Immunohistochemistry: 1:1,000-1:5,000
Immunocytochemistry: 1:1,000-1:5,000
Immunoprecipitation: 1:50-1:100

Optimal working dilutions must be determined by the end user.

Target description

27 kDa

Physical form

Format: Purified
Liquid in 100 mM Glycine, 200 mM Tris, pH 8.0.

Storage and Stability

Maintain at 2-8°C in undiluted aliquots for up to 6 months after date of receipt.

Legal Information

CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

¿No encuentra el producto adecuado?  

Pruebe nuestro Herramienta de selección de productos.

Storage Class

12 - Non Combustible Liquids

wgk_germany

WGK 1

flash_point_f

Not applicable

flash_point_c

Not applicable

Certificados de análisis (COA)

Busque Certificados de análisis (COA) introduciendo el número de lote del producto. Los números de lote se encuentran en la etiqueta del producto después de las palabras «Lot» o «Batch»

¿Ya tiene este producto?

Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.

Visite la Librería de documentos

Till Scheuer et al.
Developmental neurobiology, 79(3), 222-235 (2019-01-24)
In preterm infants, the changes from fetal life to ex-utero conditions often coincide with reduced growth and white matter damage of the cerebellum. The premature increase in arterial oxygen tension caused by preterm birth may dysregulate cerebellar development. In a
Activation of developmental nuclear fibroblast growth factor receptor 1 signaling and neurogenesis in adult brain by ?7 nicotinic receptor agonist.
Narla, ST; Klejbor, I; Birkaya, B; Lee, YW; Morys, J; Stachowiak, EK; Prokop et al.
Stem Cells Translational Medicine null
Kimberly L P Long et al.
Translational psychiatry, 11(1), 631-631 (2021-12-15)
Individual reactions to traumatic stress vary dramatically, yet the biological basis of this variation remains poorly understood. Recent studies demonstrate the surprising plasticity of oligodendrocytes and myelin with stress and experience, providing a potential mechanism by which trauma induces aberrant
Huanjia Gao et al.
Frontiers in neuroscience, 18, 1408205-1408205 (2024-07-26)
Vascular dementia (VaD) is a complex neurodegenerative disorder. We previously found that treatment of VaD in middle-aged male rats subjected to multiple microinfarction (MMI) with AV-001, a Tie2 receptor agonist, significantly improves cognitive function. Age and sex affect the development
Shen Li et al.
Brain : a journal of neurology, 142(11), 3456-3472 (2019-09-19)
The immunological barrier currently precludes the clinical utilization of allogeneic stem cells. Although glial-restricted progenitors have become attractive candidates to treat a wide variety of neurological diseases, their survival in immunocompetent recipients is limited. In this study, we adopted a
Ver todos los artículos relacionados

Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.

Póngase en contacto con el Servicio técnico